The Italian Registry of GH Treatment: electronic Clinical Report Form (e-CRF) and web-based platform for the national database of GH prescriptions

F. Pricci, M. Villa, F. Maccari, E. Agazio, D. Rotondi, P. Panei, P. Roazzi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: In Italy, the utilization and the reimbursement of Growth Hormone (rGH) therapy by the National Health System (Servizio Sanitario Nazionale) are regulated by the “Note #39” included in the “Notes for the use of drugs” by the Italian Medicines Agency (AIFA), which are published in the Official Gazette, thus having the force of law. The “Note #39” establishes the diagnosis for which the reimbursement is granted and confirms the assignment of the national health surveillance on the use of GH therapy to the Italian National Institute of Health, requesting its computerization. Aim: The aim of this work was to realize a dedicated electronic Clinical Report Form based on the mandatory data requested by the Note #39 and allowing the online reporting of the rGH prescriptions by the regional accredited centers. Results and Conclusions: This interface is at the base of the national database of the Italian Registry of GH Treatment, which allows obtaining and managing correct and complete data to provide public health surveillance on GH therapy, both at national and local levels, necessary for policymakers decisions. In addition, this national database could be a useful instrument for improving knowledge about aspects of this treatment still under discussion.

Original languageEnglish
JournalJournal of Endocrinological Investigation
DOIs
Publication statusPublished - Nov 15 2018

Fingerprint

Prescriptions
Registries
Databases
Growth Hormone
Public Health Surveillance
Health
National Institutes of Health (U.S.)
Italy
Therapeutics
Pharmaceutical Preparations

Keywords

  • Case reports
  • Database
  • Epidemiological monitoring
  • Growth hormone
  • Pharmacoepidemiology
  • Registry

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{2812261c69dc43bd97bcb5f67ca6e532,
title = "The Italian Registry of GH Treatment: electronic Clinical Report Form (e-CRF) and web-based platform for the national database of GH prescriptions",
abstract = "Background: In Italy, the utilization and the reimbursement of Growth Hormone (rGH) therapy by the National Health System (Servizio Sanitario Nazionale) are regulated by the “Note #39” included in the “Notes for the use of drugs” by the Italian Medicines Agency (AIFA), which are published in the Official Gazette, thus having the force of law. The “Note #39” establishes the diagnosis for which the reimbursement is granted and confirms the assignment of the national health surveillance on the use of GH therapy to the Italian National Institute of Health, requesting its computerization. Aim: The aim of this work was to realize a dedicated electronic Clinical Report Form based on the mandatory data requested by the Note #39 and allowing the online reporting of the rGH prescriptions by the regional accredited centers. Results and Conclusions: This interface is at the base of the national database of the Italian Registry of GH Treatment, which allows obtaining and managing correct and complete data to provide public health surveillance on GH therapy, both at national and local levels, necessary for policymakers decisions. In addition, this national database could be a useful instrument for improving knowledge about aspects of this treatment still under discussion.",
keywords = "Case reports, Database, Epidemiological monitoring, Growth hormone, Pharmacoepidemiology, Registry",
author = "F. Pricci and M. Villa and F. Maccari and E. Agazio and D. Rotondi and P. Panei and P. Roazzi",
year = "2018",
month = "11",
day = "15",
doi = "10.1007/s40618-018-0980-3",
language = "English",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",

}

TY - JOUR

T1 - The Italian Registry of GH Treatment

T2 - electronic Clinical Report Form (e-CRF) and web-based platform for the national database of GH prescriptions

AU - Pricci, F.

AU - Villa, M.

AU - Maccari, F.

AU - Agazio, E.

AU - Rotondi, D.

AU - Panei, P.

AU - Roazzi, P.

PY - 2018/11/15

Y1 - 2018/11/15

N2 - Background: In Italy, the utilization and the reimbursement of Growth Hormone (rGH) therapy by the National Health System (Servizio Sanitario Nazionale) are regulated by the “Note #39” included in the “Notes for the use of drugs” by the Italian Medicines Agency (AIFA), which are published in the Official Gazette, thus having the force of law. The “Note #39” establishes the diagnosis for which the reimbursement is granted and confirms the assignment of the national health surveillance on the use of GH therapy to the Italian National Institute of Health, requesting its computerization. Aim: The aim of this work was to realize a dedicated electronic Clinical Report Form based on the mandatory data requested by the Note #39 and allowing the online reporting of the rGH prescriptions by the regional accredited centers. Results and Conclusions: This interface is at the base of the national database of the Italian Registry of GH Treatment, which allows obtaining and managing correct and complete data to provide public health surveillance on GH therapy, both at national and local levels, necessary for policymakers decisions. In addition, this national database could be a useful instrument for improving knowledge about aspects of this treatment still under discussion.

AB - Background: In Italy, the utilization and the reimbursement of Growth Hormone (rGH) therapy by the National Health System (Servizio Sanitario Nazionale) are regulated by the “Note #39” included in the “Notes for the use of drugs” by the Italian Medicines Agency (AIFA), which are published in the Official Gazette, thus having the force of law. The “Note #39” establishes the diagnosis for which the reimbursement is granted and confirms the assignment of the national health surveillance on the use of GH therapy to the Italian National Institute of Health, requesting its computerization. Aim: The aim of this work was to realize a dedicated electronic Clinical Report Form based on the mandatory data requested by the Note #39 and allowing the online reporting of the rGH prescriptions by the regional accredited centers. Results and Conclusions: This interface is at the base of the national database of the Italian Registry of GH Treatment, which allows obtaining and managing correct and complete data to provide public health surveillance on GH therapy, both at national and local levels, necessary for policymakers decisions. In addition, this national database could be a useful instrument for improving knowledge about aspects of this treatment still under discussion.

KW - Case reports

KW - Database

KW - Epidemiological monitoring

KW - Growth hormone

KW - Pharmacoepidemiology

KW - Registry

UR - http://www.scopus.com/inward/record.url?scp=85056729337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056729337&partnerID=8YFLogxK

U2 - 10.1007/s40618-018-0980-3

DO - 10.1007/s40618-018-0980-3

M3 - Article

AN - SCOPUS:85056729337

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

ER -